Data / Drug companies / Lovastatin
Lovastatin: 22 companies and 72 products in the FDA NDC directory
Lovastatin is listed in the FDA National Drug Code Directory by 22 companies, with 72 products in commercial distribution. 72 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on February 25, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 22
- Products
- 72
- Generic (ANDA) products
- 72 (100.0%)
- Application numbers
- 3
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list lovastatin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 6 | tablet | Generic drugs (ANDA) | March 14, 2008 |
| Bryant Ranch Prepack | 5 | tablet | Generic drugs (ANDA) | November 25, 2002 |
| NuCare Pharmaceuticals,Inc. | 5 | tablet | Generic drugs (ANDA) | March 14, 2008 |
| Preferred Pharmaceuticals Inc. | 5 | tablet | Generic drugs (ANDA) | January 19, 2023 |
| Proficient Rx LP | 5 | tablet | Generic drugs (ANDA) | November 1, 2007 |
| Proficient Rx LP | 5 | tablet | Generic drugs (ANDA) | November 1, 2007 |
| Northwind Health Company, LLC | 4 | tablet | Generic drugs (ANDA) | April 10, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | November 25, 2002 |
| BluePoint Laboratories | 3 | tablet | Generic drugs (ANDA) | November 1, 2007 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | November 1, 2007 |
| Carlsbad Technology, Inc. | 3 | tablet | Generic drugs (ANDA) | November 25, 2002 |
| Golden State Medical Supply, Inc. | 3 | tablet | Generic drugs (ANDA) | December 17, 2001 |
| Lupin Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | March 14, 2008 |
| Remedyrepack Inc. | 3 | tablet | Generic drugs (ANDA) | April 2, 2021 |
| Teva Pharmaceuticals USA, Inc. | 3 | tablet | Generic drugs (ANDA) | December 17, 2001 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet | Generic drugs (ANDA) | November 25, 2002 |
| Boswell Pharmacy Services LLC D/B/A BPS Wholesale | 2 | tablet | Generic drugs (ANDA) | February 25, 2025 |
| Legacy Pharmaceutical Packaging, LLC | 2 | tablet | Generic drugs (ANDA) | November 1, 2007 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | tablet | Generic drugs (ANDA) | July 10, 2018 |
| NuCare Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | November 25, 2002 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | November 25, 2002 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | November 1, 2007 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 72 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 72 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| HMG-CoA Reductase Inhibitor | 72 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.